Menu
About Us
About Imunexus Therapeutics
Board of Directors
Executive Team
Our Philosophy
Technology
Technology Approach
Lead Product Candidates
News & Events
Company News
Conferences
Investors
Why Invest
Investor News
Corporate Governance
Email Alerts
Contact
Partnerships
Contact Us
News
Recent Posts
Imunexus R&D activities relocated to the La Trobe Institute for Molecular Science
Recommencement of Operations
Successful Capital Raise
Archives
July 2021
April 2021
March 2021
July 1st, 2021
Imunexus R&D activities relocated to the La Trobe Institute for Molecular Science
Read More
April 21st, 2021
Recommencement of Operations
Read More
March 21st, 2021
Successful Capital Raise
Read More
1
